Tazeen Ahmad
Stock Analyst at Bank of America Securities
(2.46)
# 3,017
Out of 5,074 analysts
1074
Total ratings
47.1%
Success rate
0.6%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Upgraded: Buy | $44 | $30.61 | +43.74% | 22 | Oct 23, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,157 | $875.76 | +32.11% | 72 | Oct 23, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $168 → $172 | $157.19 | +9.42% | 13 | Oct 20, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $34 | $17.61 | +93.07% | 6 | Oct 19, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $114 | $89.67 | +27.13% | 57 | Oct 19, 2026 | |
| INCY Incyte | Reiterated: Buy | $140 | $116.93 | +19.73% | 57 | Oct 19, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | n/a | $41.96 | - | 13 | Oct 16, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $667 | $535.17 | +24.63% | 31 | Oct 16, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $27 | $6.61 | +308.47% | 24 | Oct 13, 2026 | |
| AMGN Amgen | Reiterated: Sell | $317 → $328 | $447.28 | -26.67% | 9 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $891 → $908 | $819.09 | +10.85% | 15 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $20.31 | +52.63% | 50 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $227.28 | - | 51 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $242.99 | - | 75 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.78 | +92.80% | 37 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $214 | $143.29 | +49.35% | 49 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.04 | - | 53 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $15.95 | +25.39% | 53 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $90.90 | - | 45 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $18 | $18.18 | -0.99% | 72 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $7.72 | +107.25% | 24 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $36.00 | +152.78% | 3 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.35 | +259.28% | 3 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.81 | +109.97% | 24 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.92 | +67.16% | 3 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 → $144 | $110.85 | +29.91% | 18 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $150.27 | +33.09% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.95 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.20 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.24 | - | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $10.29 | - | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.01 | - | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $18.66 | +66.13% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $3.68 | -18.48% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 → $2.5 | $2.70 | -7.41% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $2.09 | +5.26% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.4057 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $79 | $11.85 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $1 | $1.60 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $0.5 | $13.94 | n/a | 7 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.71 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $3.60 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $258.92 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $25.75 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $8 | $0.1855 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $202.63 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.83 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $9.68 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 → $48 | $36.34 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $2.13 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $4.28 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $1.13 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $7.06 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $107.50 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $21.06 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $44.03 | n/a | 1 | Sep 19, 2014 |
Pharvaris
Oct 23, 2026
Upgraded: Buy
Price Target: $44
Current: $30.61
Upside: +43.74%
argenx SE
Oct 23, 2026
Reiterated: Buy
Price Target: $1,157
Current: $875.76
Upside: +32.11%
Gilead Sciences
Oct 20, 2026
Reiterated: Buy
Price Target: $168 → $172
Current: $157.19
Upside: +9.42%
Bicara Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $34
Current: $17.61
Upside: +93.07%
BioNTech SE
Oct 19, 2026
Reiterated: Buy
Price Target: $114
Current: $89.67
Upside: +27.13%
Incyte
Oct 19, 2026
Reiterated: Buy
Price Target: $140
Current: $116.93
Upside: +19.73%
Scholar Rock Holding
Oct 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $41.96
Upside: -
Vertex Pharmaceuticals
Oct 16, 2026
Reiterated: Buy
Price Target: $667
Current: $535.17
Upside: +24.63%
Ocular Therapeutix
Oct 13, 2026
Reiterated: Buy
Price Target: $27
Current: $6.61
Upside: +308.47%
Amgen
Oct 12, 2026
Reiterated: Sell
Price Target: $317 → $328
Current: $447.28
Upside: -26.67%
Oct 12, 2026
Reiterated: Buy
Price Target: $891 → $908
Current: $819.09
Upside: +10.85%
Oct 9, 2026
Reiterated: Buy
Price Target: $31
Current: $20.31
Upside: +52.63%
Oct 9, 2026
Rated: Buy
Price Target: n/a
Current: $227.28
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $242.99
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: $15
Current: $7.78
Upside: +92.80%
Oct 9, 2026
Reiterated: Buy
Price Target: $214
Current: $143.29
Upside: +49.35%
Oct 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.04
Upside: -
Oct 9, 2026
Reiterated: Hold
Price Target: $20
Current: $15.95
Upside: +25.39%
Oct 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $90.90
Upside: -
Oct 9, 2026
Reiterated: Sell
Price Target: $18
Current: $18.18
Upside: -0.99%
Oct 7, 2026
Reiterated: Hold
Price Target: $16
Current: $7.72
Upside: +107.25%
Oct 7, 2026
Reiterated: Buy
Price Target: $91
Current: $36.00
Upside: +152.78%
Sep 29, 2026
Reiterated: Buy
Price Target: $30
Current: $8.35
Upside: +259.28%
Sep 28, 2026
Reiterated: Buy
Price Target: $8
Current: $3.81
Upside: +109.97%
Sep 16, 2026
Reiterated: Buy
Price Target: $45
Current: $26.92
Upside: +67.16%
Sep 14, 2026
Reiterated: Buy
Price Target: $123 → $144
Current: $110.85
Upside: +29.91%
Sep 2, 2026
Reiterated: Buy
Price Target: $200
Current: $150.27
Upside: +33.09%
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $3.95
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.20
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $8.24
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $10.29
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.01
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $18.66
Upside: +66.13%
Aug 7, 2026
Reiterated: Sell
Price Target: $3
Current: $3.68
Upside: -18.48%
Aug 7, 2026
Reiterated: Sell
Price Target: $3 → $2.5
Current: $2.70
Upside: -7.41%
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.09
Upside: +5.26%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $0.4057
Upside: n/a
Sep 19, 2024
Reiterated: Buy
Price Target: $82 → $79
Current: $11.85
Upside: n/a
Oct 17, 2023
Reiterated: Sell
Price Target: $2 → $1
Current: $1.60
Upside: n/a
Aug 11, 2023
Downgraded: Sell
Price Target: $7 → $0.5
Current: $13.94
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $1.71
Upside: n/a
Mar 27, 2023
Reiterated: Sell
Price Target: $6
Current: $3.60
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $258.92
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $25.75
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $16 → $8
Current: $0.1855
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $202.63
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.83
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $9.68
Upside: n/a
Oct 10, 2018
Reiterated: Hold
Price Target: $46 → $48
Current: $36.34
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $2.13
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $4.28
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $1.13
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $7.06
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $107.50
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $21.06
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $44.03
Upside: n/a